292 related articles for article (PubMed ID: 23190896)
1. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens.
Friedman AJ; Phan J; Schairer DO; Champer J; Qin M; Pirouz A; Blecher-Paz K; Oren A; Liu PT; Modlin RL; Kim J
J Invest Dermatol; 2013 May; 133(5):1231-9. PubMed ID: 23190896
[TBL] [Abstract][Full Text] [Related]
2. Applications of nanoparticles for treating cutaneous infection.
Westendorf AM
J Invest Dermatol; 2013 May; 133(5):1133-5. PubMed ID: 23594534
[TBL] [Abstract][Full Text] [Related]
3. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.
Nakatsuji T; Kao MC; Fang JY; Zouboulis CC; Zhang L; Gallo RL; Huang CM
J Invest Dermatol; 2009 Oct; 129(10):2480-8. PubMed ID: 19387482
[TBL] [Abstract][Full Text] [Related]
5. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes.
McInturff JE; Wang SJ; Machleidt T; Lin TR; Oren A; Hertz CJ; Krutzik SR; Hart S; Zeh K; Anderson DH; Gallo RL; Modlin RL; Kim J
J Invest Dermatol; 2005 Aug; 125(2):256-63. PubMed ID: 16098035
[TBL] [Abstract][Full Text] [Related]
6. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.
Ghosh S; Sinha M; Bhattacharyya A; Sadhasivam S; Megha J; Reddy S; Saini S; Singh H; Kumar D; Kaur SP; Mishra M; Usharani D; Ghosh S; Sengupta S
J Invest Dermatol; 2018 Jun; 138(6):1400-1408. PubMed ID: 29409921
[TBL] [Abstract][Full Text] [Related]
7. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
Han R; Blencke HM; Cheng H; Li C
Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
Ryu S; Han HM; Song PI; Armstrong CA; Park Y
PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance in the topical treatment of acne vulgaris.
Leyden JJ
Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
[TBL] [Abstract][Full Text] [Related]
10. Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.
Wang F; Yang S; Yuan J; Gao Q; Huang C
J Biomater Appl; 2016 Jul; 31(1):3-12. PubMed ID: 27164869
[TBL] [Abstract][Full Text] [Related]
11. Topical antibiotics and topical antimicrobial agents in acne therapy.
Leyden JJ; McGinley K; Mills OH; Kligman AM
Acta Derm Venereol Suppl (Stockh); 1980; Suppl 89():75-82. PubMed ID: 6451130
[No Abstract] [Full Text] [Related]
12. SIG1459: A novel phytyl-cysteine derived TLR2 modulator with in vitro and clinical anti-acne activity.
Fernández JR; Webb C; Rouzard K; Healy J; Tamura M; Voronkov M; Huber KL; Stock JB; Stock M; Gordon JS; Pérez E
Exp Dermatol; 2018 Sep; 27(9):993-999. PubMed ID: 29797368
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus paraplantarum THG-G10 as a potential anti-acne agent with anti-bacterial and anti-inflammatory activities.
Cha H; Kim SK; Kook M; Yi TH
Anaerobe; 2020 Aug; 64():102243. PubMed ID: 32712375
[TBL] [Abstract][Full Text] [Related]
14. Developing an alginate/chitosan hybrid fiber scaffold for annulus fibrosus cells.
Shao X; Hunter CJ
J Biomed Mater Res A; 2007 Sep; 82(3):701-10. PubMed ID: 17326226
[TBL] [Abstract][Full Text] [Related]
15. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin.
Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N
Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of two plant extracts against acne vulgaris: Initial results of microbiological tests and cell culture studies.
Kılıç S; Okullu SÖ; Kurt Ö; Sevinç H; Dündar C; Altınordu F; Türkoğlu M
J Cosmet Dermatol; 2019 Aug; 18(4):1061-1065. PubMed ID: 30414245
[TBL] [Abstract][Full Text] [Related]
19. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
Sagransky M; Yentzer BA; Feldman SR
Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357
[TBL] [Abstract][Full Text] [Related]
20. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes.
Lee YJ; Choi HJ; Kang TW; Kim HO; Chung MJ; Park YM
J Microbiol Biotechnol; 2008 Jul; 18(7):1308-16. PubMed ID: 18667861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
